Wolverine Trading
TMDX icon

Wolverine Trading’s Transmedics TMDX Stock Holding History

Wolverine Trading’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6.9M Buy
61,300
+8,400
+16% +$983K 0.01% 1173
2025
Q2 		$6.95M Buy
52,900
+14,300
+37% +$1.57M 0.01% 859
2025
Q1 		$2.65M Sell
38,600
-16,900
-30% -$1.16M ﹤0.01% 1405
2024
Q4 		$3.29M Buy
55,500
+41,500
+296% +$3.86M ﹤0.01% 1526
2024
Q3 		$2.23M Buy
14,000
+6,300
+82% +$971K ﹤0.01% 1614
2024
Q2 		$1.16M Buy
7,700
+2,100
+38% +$252K ﹤0.01% 2057
2024
Q1 		$414K Sell
5,600
-1,500
-21% -$124K ﹤0.01% 3031
2023
Q4 		$560K Buy
+7,100
New +$428K ﹤0.01% 2843
2022
Q1 		– Sell
-16,300
Closed -$317K – 6430
2021
Q4 		$317K Sell
16,300
-1,500
-8% -$37.6K ﹤0.01% 4073
2021
Q3 		$566K Buy
17,800
+2,100
+13% +$64.2K ﹤0.01% 3751
2021
Q2 		$517K Buy
+15,700
New +$435K ﹤0.01% 3636

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wolverine Trading's TMDX Position: Q3 2025 in Review

Wolverine Trading increased its Transmedics (TMDX) stake by 50% in Q3 2025, buying an estimated $2.57M and bringing the position to 65,578 shares worth $7.39M. The position accounts for 0.01% of the portfolio, ranked #1125.

Wolverine Trading first reported a position in TMDX in Q4 2021 and has held it in 9 quarters since. 388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

  • Wolverine Trading held 65,578 shares of Transmedics worth $7.39M as of Q3 2025.
  • Wolverine Trading bought 21,985 Transmedics shares in Q3 2025, an estimated $2.57M.
  • Transmedics made up 0.01% of Wolverine Trading's portfolio in Q3 2025, its #1125 holding.
  • Wolverine Trading first reported a position in Transmedics in Q4 2021 and has held it in 9 quarters since.
  • 388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.